ArticleSignal transduction and targeted therapy2021
Longitudinal dynamics of antibody responses in recovered COVID-19 patients.
Article in Signal transduction and targeted therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- COVID-19: from immune response to clinical intervention.Precision clinical medicine · 2024Review
- A pangolin-origin SARS-CoV-2-related coronavirus: infectivity, pathogenicity, and cross-protection by preexisting immunity.Cell discovery · 2023Article
- Article
- Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.Frontiers in immunology · 2023Review
- Ultrarapid and ultrasensitive detection of SARS-CoV-2 antibodies in COVID-19 patients via a 3D-printed nanomaterial-based biosensing platform.Journal of medical virology · 2022Article
- Natural humoral immunity per year after SARS-CoV-2 infection in hospitalized patients.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2022Article
- Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study.Clinical kidney journal · 2022Article
- Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients.Frontiers in immunology · 2022Article
- Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera.Microbiology spectrum · 2021Article
- Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.Viruses · 2021Article
- SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals.Frontiers in immunology · 2021Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.